Prebiotics targeting gut-liver axis to treat non-alcoholic fatty liver disease.

Castelnuovo, Gabriele; Perez-Diaz-Del-Campo, Nuria; Guariglia, Marta; Poggiolini, Irene; Armandi, Angelo; Rosso, Chiara; Caviglia, Gian P; Bugianesi, Elisabetta

Castelnuovo, Gabriele; Perez-Diaz-Del-Campo, Nuria; Guariglia, Marta; Poggiolini, Irene; Armandi, Angelo; Rosso, Chiara; Caviglia, Gian P; Bugianesi, Elisabetta.

Afiliação

Castelnuovo G; Department of Medical Sciences, University of Turin, Turin, Italy.
Perez-Diaz-Del-Campo N; Department of Medical Sciences, University of Turin, Turin, Italy.
Guariglia M; Department of Medical Sciences, University of Turin, Turin, Italy.
Poggiolini I; Department of Medical Sciences, University of Turin, Turin, Italy.
Armandi A; Department of Medical Sciences, University of Turin, Turin, Italy.
Rosso C; Metabolic Liver Disease Research Program, First Department of Medicine, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Caviglia GP; Department of Medical Sciences, University of Turin, Turin, Italy.
Bugianesi E; Department of Medical Sciences, University of Turin, Turin, Italy - gianpaolo.caviglia@unito.it.

Minerva Gastroenterol (Torino) ; 2023 Mar 09.

Article em En | MEDLINE | ID: mdl-36892817

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Minerva Gastroenterol (Torino) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google